Some commentary on Aduhelm and the crazy US health system.
No wonder Biogen wanted to rush this to market to rescue their business.
We are not under the same pressure.
https://www.theatlantic.com/ideas/archive/2021/06/aduhelm-drug-alzheimers-cost-medicare/619169/
"Earlier this week, the Food and Drug Administration overruled—to much criticism—its own scientific advisory committee and approved the Alzheimer’s treatment Aduhelm. The agency made this decision despite thin evidence of the drug’s clinical efficacy and despite its serious side effects, including brain swelling and bleeding. As a result, a serious risk now exists that millions of people will be prescribed a drug that does more harm than good."
https://www.fiercepharma.com/pharma/biogen-fda-aducanumab-decision
"For Biogen, the company's all-in bet on aducanumab, now marketed as Aduhelm, comes amid serious troubles elsewhere in its business. Multiple sclerosis drug Tecfidera and spinal muscular atrophy med Spinraza have been facing increasing competitive pressures, leading the company to post a sales decline in 2020."
- Forums
- ASX - By Stock
- PI3K Drugs for Alzheimers
Some commentary on Aduhelm and the crazy US health system.No...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online